Identification of minimal regions of deletion at 8p23.1-22 associated with metastasis of hepatocellular carcinoma

被引:12
作者
Lu, Tomoe [1 ]
Hano, Hiroshi [1 ]
机构
[1] Jikei Univ, Sch Med, Dept Pathol, Minato Ku, Tokyo 1058461, Japan
关键词
hepatocellular carcinoma; loss of heterozygosity; metastasis; 8p;
D O I
10.1111/j.1478-3231.2007.01504.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Aims/ Background: Loss of heterozygosity ( LOH) at 8p is the most frequent chromosomal alteration in tumorigenesis of human cancers. However, the genetic change in metastasis of hepatocellular carcinoma ( HCC) still has to be investigated. Methods: We used 16 microsatellite markers informative in Japanese patients, selected from among 61 published microsatellite markers at 8p23.2- 21 to compare the frequency of LOH in primary tumours ( Tps) and metastatic tumours ( Tms) in a PCR- based analysis. Sixty- three informative cancerous lesions ( 26 were Tps, 37 were Tms) from 23 cases of HCC were used. Results: The frequency of LOH at 8p23.2- 21 with at least one marker was 19% in Tps and 68% in Tms. Allelic loss at 8p23.2- 21 was significantly more frequent in Tms than in Tps ( P= 0.0003). More specifically, the frequency of LOH at D8S262, D8S1819, D8S503, D8S1130, D8S552, D8S1109, and D8S261 in Tms was 36 - 60% respectively. Conclusions: In contrast, allelic loss at the same markers in Tp was only detected in 0 - 17% of the tumour respectively. The significant difference in the frequency of LOH at 8p between primary cancer and metastatic cancer in individual cases of HCC suggests LOH at 8p to be involved in the enhancement of tumour aggressiveness, especially during metastasis.
引用
收藏
页码:782 / 790
页数:9
相关论文
共 29 条
[1]  
Bando K, 1999, GENE CHROMOSOME CANC, V25, P284, DOI 10.1002/(SICI)1098-2264(199907)25:3<284::AID-GCC11>3.3.CO
[2]  
2-9
[3]  
Bockmuhl U, 1997, CANCER RES, V57, P5213
[4]   Primary liver cancer:: Worldwide incidence and trends [J].
Bosch, FX ;
Ribes, J ;
Díaz, M ;
Cléries, R .
GASTROENTEROLOGY, 2004, 127 (05) :S5-S16
[5]   Focus on hepatocellular carcinoma [J].
Bruix, J ;
Boix, L ;
Sala, M ;
Llovet, JM .
CANCER CELL, 2004, 5 (03) :215-219
[6]   High-density allelotyping of chromosome 8p in hepatocellular carcinoma and clinicopathologic correlation [J].
Chan, KL ;
Lee, JMF ;
Guan, XY ;
Fan, ST ;
Ng, IOL .
CANCER, 2002, 94 (12) :3179-3185
[7]   Molecular genetic evidence supporting a novel human hepatocellular carcinoma tumor suppressor locus at 13q 12.11 [J].
Chen, CF ;
Yeh, SH ;
Chen, DS ;
Chen, PJ ;
Jou, YS .
GENES CHROMOSOMES & CANCER, 2005, 44 (03) :320-328
[8]  
DESMET VJ, 1994, HEPATOLOGY, V19, P1513, DOI 10.1002/hep.1840190629
[9]   Structural organization and expression of human MTUS1, a candidate 8p22 tumor suppressor gene encoding a family of angiotensin II AT2 receptor-interacting proteins, ATIP [J].
Di Benedetto, M. ;
Bieche, I. ;
Deshayes, F. ;
Vacher, S. ;
Nouet, S. ;
Collura, V. ;
Seitz, I. ;
Louis, S. ;
Pineau, P. ;
Amsellem-Ouazana, D. ;
Couraud, P. O. ;
Strosberg, A. D. ;
Stoppa-Lyonnet, D. ;
Lidereau, R. ;
Nahmias, C. .
GENE, 2006, 380 (02) :127-136
[10]   Mutation analysis of the 8p22 candidate tumor suppressor gene ATIP/MTUS1 in hepatocellular carcinoma [J].
Di Benedetto, M. ;
Pineau, P. ;
Nouet, S. ;
Berhouet, S. ;
Seitz, I. ;
Louis, S. ;
Dejean, A. ;
Couraud, P. O. ;
Strosberg, A. D. ;
Stoppa-Lyonnet, D. ;
Nahmias, C. .
MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2006, 252 (1-2) :207-215